NCT01811121View on ClinicalTrials.gov

MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS

PHASE3CompletedINTERVENTIONAL

Enrollment

170

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

March 31, 2013

Study Completion Date

August 31, 2019

Conditions

Glioblastoma

Interventions

DRUG

5-aminolévulinique acid (5-ALA)

oral administration of 20mg/kg of 5-ALA 3-5 hours before the surgical incision

DRUG

Placebo

Oral administration of 1g of ascorbic acid LAROSCORBINE in 50ml of water 3 hours before surgery

Trial Locations (1)

Unknown

Guyotat, Lyon

All Listed Sponsors

lead

Hospices Civils de Lyon

OTHER

NCT01811121 - MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS | Biotech Hunter | Biotech Hunter